What Is Good Clinical Practice (GCP)?
There are international protections provided to humans participating in research, rightfully so. The foundation of the ethical and scientific standards for designing, conducting, documenting, and reporting clinical trials is established in Good Clinical Practice (GCP). GCP is not a single document to adhere to or a law to follow, it is a set of principles most widely codified in the International Council for Harmonisation (ICH) E6 guidelines. These guidelines govern how clinical trials are run to ensure that participants rights and satay are protected and for the resulting data to be trusted.
Anyone working in any capacity in clinical research, GCP is the framework all other guidelines are built upon. Let’s dig in. Bit deeper to make sure we have appropriate understanding.
As an important note, please make sure to review all current relevant guidelines as information as of this article’s publication date may be out of date.
Where Good Clinical Practice (GCP) Comes From
Throughout the 20th century there have been severe research ethics failures resulting in the formal protection for human research subjects. These were detailed and codified in the Nuremberg Code and the Declaration of Helsinki. These were used to establish operational guidance in the multiple updates of ICH guidelines.
GCP in the United States are reinforced through FDA regulation. This includes regulatory requirements for informed consent (21 CFP Parts 50), Institutional Review Boards (Parts 56), and investigational new drug applications (Parts 312). Even though GCP is not a U.S. law, by following FDA regulations for clinical research or ICH compliance with sponsors, GCP is applied.
The Core Principles of GCP
Take some time to review the full ICH E6 guideline to ensure you remain informed and up to date. It runs too long to get into here, but the underlying principles boil down to a few consistent themes:
Participant Rights and Safety Come First
Patient rights, safety, and welfare should always be prioritized over scientific or business interests. This ethical center of gravity should inform decision making at the research site. From protocol design to reporting, participant rights should always be considered first.
Informed Consent Must Be Genuine
Informed consent is more than a form, it is the most important ongoing discussion. Patients must have the time to understand and discuss the study before enrolling. They must understand the benefits and potential harms and that there is no penalty to withdraw.
Qualified People, Clearly Defined Roles
A delegation of authority log is a crucial document to ensure the right people are doing the right things in the trial. Every individual that makes up part of the clinical research team must be qualified by education, training, and experience for the task they must perform. Proper documentation of all of this is a must as well.
Data Must Be Reliable and Verifiable
Proper documentation of all aspects of the trial is not optional but a must. This can be accomplished by following ALCOA-C principles and ensuring all staff are trained on proper documentation.
Independent Ethical Oversight
As patient protection is the priority across all clinical trial phases, there are independent bodies that provide research oversite. IRBs and ethics committees are required to review a study and related protocol before it begins. They are also responsible for the continuous monitoring of the trial to ensure the protection remains through the entirety of the study.
Protocol Adherence
Sponsor-approved protocols must be adhered to by all Investigators and site staff. Any deviations to the protocol must be documented, assessed for participant impact, and reported appropriately rather than quietly absorbed.
Why GCP Matters Beyond Compliance
It's easy to think of GCP as a regulatory checkbox, but for a site, it functions more like an operating system. GCP helps with study selection as study sponsors and CROs will review a site's GCP track record. A history of strong documentation and a clean GCP record can help get more studies.
Similarly, GCP helps ensure study integrity. GCP violation, intentional or unintentional, can compromise a study’s data. This can build up to delay or derail treatments patients may be waiting on. Following GCP and documentation requirements is also the best way to protect the site and site staff from potential liabilities.
Adhering to GCP requirements is not complicated in isolation. New sites typically find themselves with GCP violations not because they don't know the rules, but because they did not build habits around the rules. With proper training, SOPs, and systematic processes, following GCP becomes the path of least resistance.
Getting Started with GCP
Most CROs and sites require documented GCP training before staff can work on a study with a refresher annually or every few years. Options range widely in depth and cost, from free online modules to structured courses built around practical application rather than just terminology. Multiple trainings covering GCP foundations, ALCOA-C, informed consent and others are great places to start as they target compliance hot spots.
GCP can seem intimidating for a new site considering clinical research for the first time. It is best to approach it as system building as opposed to a checkbox. Sites that build those habits early tend to find that GCP compliance stops feeling like an external requirement and starts feeling like how they'd want to run things anyway.
For sites weighing whether to build this infrastructure internally or bring in outside support during the early stages, that's often where a site management partnership earns its keep. This does not replace a site's clinical judgment, but makes sure the systems around it meet the standard from day one.
Comments